BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradation
被引:52
作者:
Shabbeer, S.
论文数: 0引用数: 0
h-index: 0
机构:
Georgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA
Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USAGeorgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA
Shabbeer, S.
[1
,2
]
Omer, D.
论文数: 0引用数: 0
h-index: 0
机构:
Chaim Sheba Med Ctr, Dept Surg Oncol, Lab Genom Applicat, IL-52621 Tel Hashomer, IsraelGeorgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA
Omer, D.
[3
]
Berneman, D.
论文数: 0引用数: 0
h-index: 0
机构:
Chaim Sheba Med Ctr, Dept Surg Oncol, Lab Genom Applicat, IL-52621 Tel Hashomer, IsraelGeorgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA
Berneman, D.
[3
]
Weitzman, O.
论文数: 0引用数: 0
h-index: 0
机构:
Chaim Sheba Med Ctr, Dept Surg Oncol, Lab Genom Applicat, IL-52621 Tel Hashomer, IsraelGeorgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA
Weitzman, O.
[3
]
Alpaugh, A.
论文数: 0引用数: 0
h-index: 0
机构:
Georgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USAGeorgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA
Alpaugh, A.
[1
]
论文数: 引用数:
h-index:
机构:
Pietraszkiewicz, A.
[1
]
Metsuyanim, S.
论文数: 0引用数: 0
h-index: 0
机构:
Chaim Sheba Med Ctr, Dept Surg Oncol, Lab Genom Applicat, IL-52621 Tel Hashomer, IsraelGeorgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA
Metsuyanim, S.
[3
]
Shainskaya, A.
论文数: 0引用数: 0
h-index: 0
机构:
Weizmann Inst Sci, Laraine & Alan A Fischer Lab Biol Mass Spectromet, IL-76100 Rehovot, IsraelGeorgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA
Shainskaya, A.
[4
]
Papa, M. Z.
论文数: 0引用数: 0
h-index: 0
机构:
Chaim Sheba Med Ctr, Dept Surg Oncol, Lab Genom Applicat, IL-52621 Tel Hashomer, IsraelGeorgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA
Papa, M. Z.
[3
]
Yarden, R. I.
论文数: 0引用数: 0
h-index: 0
机构:
Georgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA
Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA
Chaim Sheba Med Ctr, Dept Surg Oncol, Lab Genom Applicat, IL-52621 Tel Hashomer, IsraelGeorgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA
Yarden, R. I.
[1
,2
,3
]
机构:
[1] Georgetown Univ, Med Ctr, Dept Human Sci, SNHS, Washington, DC 20057 USA
[2] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA
[3] Chaim Sheba Med Ctr, Dept Surg Oncol, Lab Genom Applicat, IL-52621 Tel Hashomer, Israel
[4] Weizmann Inst Sci, Laraine & Alan A Fischer Lab Biol Mass Spectromet, IL-76100 Rehovot, Israel
The BRCA1 tumor suppressor protein heterodimerizes with its partner protein, BARD1, via the RING domain present in both proteins. The heterodimer contains an E3 ubiquitin ligase activity and participates in multiple cellular functions such as cell cycle control, DNA repair and regulation of gene transcription, collectively aimed at maintaining genomic stability and tumor suppression. Yet, the precise role of BRCA1 E3 ligase in these cellular functions is poorly understood. We present data showing that BRCA1 ubiquitinates G2/M cell cycle proteins, cyclin B and Cdc25C, leading to their accelerated degradation via a mechanism that is independent of APC/C. BRCA1-dependent degradation of cyclin B and Cdc25C is reversed by proteasome inhibitors and is enhanced following DNA damage, which may represent a possible mechanism to prevent cyclin B and Cdc25C accumulation, a requirement for mitotic entry. Our data provide mechanistic insight into how BRCA1 E3 ligase activity regulates the G2/M cell cycle checkpoint and, thus, contributes to maintenance of genomic stability.